Please join us along with the world’s leaders in Neisseria research and vaccine development at the 22nd International Pathogenic Neisseria Conference (IPNC 2022) in Cape Town, South Africa, October 9-14, 2022.  We're looking forward to meeting with you to learn more about your vaccine development projects and how we may help you source critical reagents for your vaccine immunogenicity assays.  

Stop by our booth to meet our CTO, Dr. Chris Lyle, and our Director of Strategic Partnerships, Dr. Robert Natuk.  They will be available to answer your questions about our IgG/IgM Antibody-Depleted Human Complement (ADHC), IgG/IgM Antibody-Depleted Human Serum (ADHS), Baby Rabbit Complement (BRC), and more.

As a world leader in complement serum, we offer these products in large lots (>5 L) to satisfy your needs throughout the vaccine development life cycle, from assay to development to high-throughput clinical testing.

We look forward to seeing you in Cape Town!